fbpx

MedTech

Med-In Pharma logo

Med-In Pharma at Med-Tech world

The Med-In Pharma 2022 Conference will be taking place between 17 and 18 November 2022 at the Hilton, Malta, and will form part of the Malta Med-Tech World Summit 2022. The Med-In Pharma 2022 Conference will offer the opportunity for discussions on policy-making and regulation, health inquiry, medical innovation, digital health and personalised, patient-focused technology. The Conference promotes best practice and fosters dialogue to ensure innovation can take place in a secure manner that safeguards the public.

Med-In Pharma 2022 is being organized in collaboration with the Faculty of Medicine and Surgery of the University of Malta.  The conference will be held over two (2) full days with an audience of approximately two hundred (200) academics, professionals and students and will focus on Innovative Techniques in Medicine, Enabling Technologies, Smart Factory and Future Trends in Pharmacy. The conference will consist of plenary sessions, short communication sessions and poster presentations.

Members of the scientific community practicing in the field of medicine, surgery, dentistry, pharmacy and applied sciences are invited to prepare abstracts related to innovative techniques in medicine, surgery and dentistry enabling technologies, smart factory and future trends in pharmacy and applied sciences for submission to the scientific committee of the Med-In Pharma 2022 Conference.

Abstracts are to be submitted by 26 October 2022. Abstracts will be offered to be presented as a short oral communication or a poster presentation. Authors will be notified on the final results of the review process by 8 November 2022. Accepted abstracts are to be presented by one of the authors who must register for the Malta Med-Tech World Summit 2022

Partners

Medical devices and technology are the future of healthcare. I have been at the forefront of this in my surgical career both in Malta and beyond. Cutting-edge technology allowed us to do now what we thought would be impossible before. An ageing population also needs better care, more frequent monitoring, and adequate companionship and technology can bridge the gap that exists in human resources. Through the Malta Medicines Authority, we want to make sure that medical devices and software being introduced in the market are robust, clinically safe and do their intended purpose. We are taking the necessary steps for the Malta Medicines Authority to establish itself as European Competent Authority, excelling in the evaluation and approval of devices. We want Med-Tech World and its side-events to showcase not only innovation but also the strides in device regulation that will ensure that products entering the market make a difference in our lives without causing harm.

Over the years we have built the Malta Medicines Authority as one of the leading regulatory bodies in Europe. We recently have re-affirmed this through regulation of medical cannabis products and looking to increase our presence in the medical device industry. I believe that through conferences such as this, we can increase awareness about what is happening in the industry and can showcase why Malta is becoming a powerhouse in regulation. I also think that a scientific component through the presentation of research is essential, and that is why a scientific poster presentation will feature in Med-In Pharma to allow researches to show their work in an international forum to stimulate innovation.


Thursday 17th November 2022 (Med-In Pharma)

08:30-09:00

Registration / Welcome Coffee

09:00-09:30

Opening Ceremony

09:00-09:30
Opening address
09:00-09:30
Welcome on behalf of Faculty of Medicine & Surgery, University of Malta
09:00-09:30
Welcome on behalf of Faculty of Medicine and Surgery, University of Malta
09:00-09:30
Welcome on behalf of the Department of Surgery, Mater Dei Hospital
09:00-09:30
Welcome on behalf of the Malta Medicines Authority

PROF ANTHONY SERRACINO INGLOTT

Professor at University of Malta & Chairman at Malta Medicines Authority
09:30-11:30

SESSION 1: Trends in Surgery - Too Slow or Too Fast?

09:30-10:00
Latest trends in surgical practice in Latin America
10:00-10:30
Latest in trauma management – is there a role for laparoscopy?

Mr Euan J Dickson

Consultant Surgeon at West of Scotland Pancreatic Unit, Glasgow Royal Infirmary
10:30-11:00
Is minimally invasive oesophageal and pancreatic resection feasible in a low/medium volume centre?

Hon. Dr. Jo-Etienne Abela, Minister for Active Ageing & Malta Medicines Authority

11:00-11:30
Cutting edge dental surgery – From the perspective of the Royal Colleges
11:30-11:50

Coffee Break and Poster Presentations

11:50-13:50

Session 2: The future: A Promise or Uncertainty

11:50-12:20
Advances in computationally guided surgery, from quantification to artificial intelligence
12:20-12:50
Colorectal Endoscopic Submucosal Dissection (ESD) – The minimally invasive revolution!
12:50-13:20
Endoscopic solutions for morbid obesity
13:20-13:50
Endovascular solutions for aortic pathology
13:50-14:40

Networking Lunch

14:40-16:40

Session 3: Open Surgery- forgotten technique?

14:40-15:10
Cutting edge interventional radiology – for whom the bell tolls?!
15:10-15:40
Adrenal Surgery – open is not an option
15:40-16:10
The future of AI in the Operating Room
16:10-16:40
The Death of Surgery
16:40-17:15

Round-Table discussion - Will open surgery survive the next 10 years?

16:40-17:15
Aye
16:40-17:15
Nay
17:15-17:30

Closing Remarks

Friday 18th November 2022 (Med-In Pharma)

08:30-09:00

Registration / Welcome Coffee

09:00-10:30

Session 4: Smart Factory

09:00-09:30
Quality by design as a facilitator for Pharma industry 4.0
09:30-10:00
Robotic automation in pharmaceutical manufacturing
10:00-10:30
Innovative facility options in a new era of urgent capacity needs
10:30-10:55

Short Oral Communications: Session A

10:30-10:55
Remote Monitoring with Cardiac Implantable Electronic Devices: Patient Benefits and Challenges
10:30-10:55
Transdermal Drug Delivery Systems: A Risk Analysis
10:30-10:55
Fora Antenna for Microwave Breast Cancer Hyperthermia
10:30-10:55
The MK2 Cascade Mediates Transient Alteration in Mglur-LTD and Spatial Learning in a Murine Model of Alzheimer's Disease
10:30-10:55
On the Feasibility of Remotely Administered and Self- Driven Cognitive Assessments using a Multimodal Dialog Agent
10:55-11:20

Coffee Break and Poster Presentations

11:20-12:50

Session 5: Enabling Technologies

11:20-11:50
Application of 3D Printing and Design of Experiments for the Development of Pharmaceutical Products
11:50-12:20
Using AI and robotics surgery to revolutionize scoliosis surgery
11:50-12:20
Using AI and robotics surgery to revolutionize scoliosis surgery
12:20-12:50
New Robotic Concepts
12:50-13:15

Short Oral Communications: Session B

12:50-13:15
Virtual Player Optimization
12:50-13:15
Predicting Drug-Drug Interactions using Knowledge Graphs
12:50-13:15
Accreditation Perspectives for the Analysis of Cannabinoids
12:50-13:15
Updates on the Regulatory Landscape of Cannabis for Medicinal and Research Purposes in Malta
12:50-13:15

Academy for Patient Centred Excellence and Innovation in Regulatory Sciences: A Gateway to Advanced Education

13:15-14:00

Networking Lunch

14:00-16:00

Session 6: Future Trends

14:00-14:30
Towards a smart and agile Pharmacy 5.0 education
14:30-15:00
Deployment of digital twins along the product life cycle 
15:00-15:30
Clinical trials – Challenges and real-world data
15:30-16:00
Human-robot collaboration and safety in industry 4.0
16:00-16:30

Round-Table Discussion

16:00-16:30
Pharma 4.0 – The soft and hard skills
16:30-16:45

Closing Remarks

speakers

DR JOSIANNE CUTAJAR

MR. JEFFREY DALLI

MR EUAN J DICKSON

DR. RAKESH KALAPALA
MD, DNB (Gastroenterology)

ELENI TSINTAVI

THOMAS HAUSER

PROFESSOR FERDINAND SERRACINO-INGLOTT

PROFESSOR DIMITRIOS M.REKKAS

PANORIOS BENARDOS

CHRISTOPH HERWIG

STAVROS POLITIS

DR. EDWARD JOHN DESPOTT

EREZ LAMPERT

HON. DR. JO-ETIENNE ABELA

DR. AMIR SZOLD

ANTONELLO FORGIONE MD PHD MBA FACS

PROFESSOR MANISH CHAND

PROF. LILIAN M. AZZOPARDI

PROF ANTHONY SERRACINO INGLOTT

Partners